Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Orally Bioavailable 4-Phenoxy-quinoline Compound as a Potent Aurora Kinase B Relocation Blocker for Cancer Treatment

Published:2023-07-21 Issue:8 Volume:6 Page:1155-1163
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Li Jinhua¹²,Zhang Ting¹²,Shi Qiong¹²,Lv Gang¹²,Zhou Xiaohu¹²,Choudhry Namrta¹²,Kalashova Julia¹²,Yang Chenglu¹²,Li Hongmei¹²,Long Yan¹²,Sakthivel Balasubramaniyan³,Nimishetti Naganna¹²,Liu Hong⁴,Allen Thaddeus D.⁴^ORCID,Zhang Jing¹²,Yang Dun¹²^ORCID

Affiliation:

1. Chengdu Anticancer Bioscience, Chengdu 610000, China

2. J. Michael Bishop Institute of Cancer Research, Chengdu 610000, China

3. Anticancer Bioscience (India), Hyderabad 500051, India

4. Anticancer Bioscience (US), South San Francisco, California 94080, United States

Funder

Anticancer Bioscience

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.3c00054

Reference14 articles.

1. The functional diversity of Aurora kinases: a comprehensive review

2. Aurora Kinases: New Targets for Cancer Therapy

3. The chromosomal passenger complex (CPC) as a key orchestrator of orderly mitotic exit and cytokinesis

4. Aurora Kinase B Inhibition: A Potential Therapeutic Strategy for Cancer

5. Activation of tyrosine kinases by mutation of the gatekeeper threonine

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC amplifies mitotic perturbations elicited by LXY18 to enable synthetic lethality;2023-11-09

2. The Aurora kinase B relocation blocker LXY18 triggers mitotic catastrophe selectively in malignant cells;PLOS ONE;2023-10-30

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3